ABBY RATHMAN: Open Payments
NPI 1104155878 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 86 payments from 15 companies in 2025. Trend: 2023 $1,296 · 2024 $1,444 · 2025 $1,550
Food & beverage: $1,550
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $299 |
| Madrigal Pharmaceuticals | 5 | $239 |
| ABBVIE INC. | 28 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Regeneron Healthcare Solutions, Inc. | 7 | $134 |
| GENZYME CORPORATION | 5 | $130 |
| PFIZER INC. | 6 | $104 |
| Ardelyx, Inc. | 3 | $72 |
| Intercept Pharmaceuticals, Inc. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $34 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, ENTYVIO, CREON, IBSRELA, RINVOQ, VELSIPITY.
Industry payments across PA — which companies pay providers there.
